C4 Therapeutics, Inc. (CCCC)
2.93
-0.04
(-1.35%)
USD |
NASDAQ |
May 06, 16:00
2.92
-0.01
(-0.34%)
After-Hours: 20:00
C4 Therapeutics Total Liabilities (Quarterly) : 115.35M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | 117.21B |
| Biogen, Inc. | 10.83B |
| Merck & Co., Inc. | 82.75B |
| Bristol Myers Squibb Co. | 66.37B |
| BrightSpring Health Services, Inc. | 4.223B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 371.94M |
| Shareholders Equity (Quarterly) | 256.59M |
| Debt to Equity Ratio | 0.2338 |
| Current Ratio | 7.814 |
| Net Debt Paydown Yield | 0.77% |